The Unicompartmental Knee Resurfacing Prosthesis (UniCAP®) incorporates a low-profile femoral articular component that mates to a taper post via a taper interlock. The femoral component articulates against an all-polyethylene tibial component. The UniCAP® implants allow resurfacing of the compartment utilizing the undisturbed compartmental structures and soft-tissues.
Articular Component: Cobalt-Chronium Alloy (Co-Cr-Mo)
Surface Coating: Titanium (CPTi)
Taper Post: Titanium Alloy (Ti-6Al-4V)
Tibial Component: Ultra-High-Molecular Weight Polyethylene (UHMWPE)
Partial replacement of the articulating surfaces of the knee when only one side of the joint is affected due to the compartmental primary degenerative or post-traumatic degenerative disease, previous tibial condyle or plateau fractures, deformity or revision of previous arthroplasty. This device is intended to be used with bone cement.
Absolute contraindications include:
1) Infection, sepsis, or osteomyelitis
2) Patients that have a known sensitivity to materials typically used in orthopedic prosthetic
devices or bone cements
Relative contraindications include:
1) Uncooperative patient or patient incapable of following pre-operative and
3) Metabolic disorders which may impair the formation or healing of bone
4) Infections at remote sites which may spread to the implant site
5) Rapid joint destruction or bone resorption visible on roentgenogram
6) Chronic instability or deficient soft tissues and other support structures
7) Vascular or muscular insufficiency
8) Inadequate skin, musculotendinus or neurovascular system status
The HemiCAP® implants intraoperatively recreate the patients' articular cartilage surface convexities. This unique mapping technology enables the surgeon to place the implant so the implant becomes part of the patient's natural curvatures - both in the medial to lateral aspect as well as the anterior to posterior plane.
RegJoint™ is indicated for arthroplasties in small joints in hand and foot for patients suffering of rheumatoid arthritis or osteoarthritis. The specific target joints are metatarsal I-V, V (MTI I-V) in foot, carpometacarpal (CMC I) and metacarpophalangeal II-V (MCP II-V) joints in hand.
MED&CARE Sp. z o.o.
ul. Mławska 13
81-204 Gdynia, Poland
phone: +48 58 776 22 75
fax: +48 58 350 97 57
mobile: +48 506 399 272
Number: PL 92 1020 1853 0000 9502 0124 1017
Bank PKO BP SA, I Oddział w Gdyni
Kod BIC (Swift): BPKOPLPW